Overview

The marketing authorisation for Enzepi has been withdrawn at the request of the marketing authorisation holder.

Enzepi : EPAR - Summary for the public

български (BG) (621.78 KB - PDF)
español (ES) (540.43 KB - PDF)
čeština (CS) (604.89 KB - PDF)
dansk (DA) (536.24 KB - PDF)
Deutsch (DE) (543.01 KB - PDF)
eesti keel (ET) (535.46 KB - PDF)
ελληνικά (EL) (625.77 KB - PDF)
français (FR) (541.13 KB - PDF)
hrvatski (HR) (559.2 KB - PDF)
italiano (IT) (540.18 KB - PDF)
latviešu valoda (LV) (594.41 KB - PDF)
lietuvių kalba (LT) (562 KB - PDF)
magyar (HU) (597.75 KB - PDF)
Malti (MT) (606.17 KB - PDF)
Nederlands (NL) (1003.58 KB - PDF)
polski (PL) (603.85 KB - PDF)
português (PT) (540.48 KB - PDF)
română (RO) (564.35 KB - PDF)
slovenčina (SK) (603.73 KB - PDF)
slovenščina (SL) (597.53 KB - PDF)
Suomi (FI) (535.49 KB - PDF)
svenska (SV) (537.16 KB - PDF)

Product information

Enzepi : EPAR - Product Information

български (BG) (1.75 MB - PDF)
español (ES) (931.36 KB - PDF)
čeština (CS) (1.44 MB - PDF)
dansk (DA) (906.51 KB - PDF)
Deutsch (DE) (930.41 KB - PDF)
eesti keel (ET) (976.01 KB - PDF)
ελληνικά (EL) (1.83 MB - PDF)
français (FR) (935.97 KB - PDF)
hrvatski (HR) (973.31 KB - PDF)
íslenska (IS) (912.11 KB - PDF)
italiano (IT) (925.82 KB - PDF)
latviešu valoda (LV) (1.51 MB - PDF)
lietuvių kalba (LT) (1012.36 KB - PDF)
magyar (HU) (1.45 MB - PDF)
Malti (MT) (1.5 MB - PDF)
Nederlands (NL) (1.53 MB - PDF)
norsk (NO) (952.94 KB - PDF)
polski (PL) (1.49 MB - PDF)
português (PT) (913.38 KB - PDF)
română (RO) (1.02 MB - PDF)
slovenčina (SK) (1.45 MB - PDF)
slovenščina (SL) (1.41 MB - PDF)
Suomi (FI) (901.4 KB - PDF)
svenska (SV) (907.25 KB - PDF)

Latest procedure affecting product information: T/01

02/09/2016

Globe icon

This medicine’s product information is available in all official EU languages.
Select 'available languages' to access the language you need.

Product information documents contain:

  • summary of product characteristics (annex I);
  • manufacturing authorisation holder responsible for batch release (annex IIA);
  • conditions of the marketing authorisation (annex IIB);
  • labelling (annex IIIA);
  • package leaflet (annex IIIB).

Enzepi : EPAR - All Authorised presentations

български (BG) (596.25 KB - PDF)
español (ES) (520.37 KB - PDF)
čeština (CS) (561.4 KB - PDF)
dansk (DA) (514.95 KB - PDF)
Deutsch (DE) (527.99 KB - PDF)
eesti keel (ET) (520.86 KB - PDF)
ελληνικά (EL) (565.89 KB - PDF)
français (FR) (536.94 KB - PDF)
hrvatski (HR) (551.61 KB - PDF)
íslenska (IS) (522.31 KB - PDF)
italiano (IT) (519.21 KB - PDF)
latviešu valoda (LV) (567.89 KB - PDF)
lietuvių kalba (LT) (562.34 KB - PDF)
magyar (HU) (584.06 KB - PDF)
Malti (MT) (561.52 KB - PDF)
Nederlands (NL) (975.32 KB - PDF)
norsk (NO) (509.71 KB - PDF)
polski (PL) (559.86 KB - PDF)
português (PT) (521.29 KB - PDF)
română (RO) (548.73 KB - PDF)
slovenčina (SK) (583.82 KB - PDF)
slovenščina (SL) (542.36 KB - PDF)
Suomi (FI) (516.06 KB - PDF)
svenska (SV) (512.27 KB - PDF)

Product details

Name of medicine
Enzepi
Active substance
pancreas powder
International non-proprietary name (INN) or common name
pancreas powder
Therapeutic area (MeSH)
Exocrine Pancreatic Insufficiency
Anatomical therapeutic chemical (ATC) code
A09AA02

Pharmacotherapeutic group

Digestives, incl. enzymes

Therapeutic indication

Pancreatic enzyme replacement treatment in exocrine pancreatic insufficiency due to cystic fibrosis or other conditions (e.g. chronic pancreatitis, post pancreatectomy or pancreatic cancer).
Enzepi is indicated in infants, children, adolescents and adults.

Authorisation details

EMA product number
EMEA/H/C/002070
Marketing authorisation holder
Allergan Pharmaceuticals International Ltd

Clonshaugh Business Technology Park
Coolock
Dublin
D17 E400
Ireland

Marketing authorisation issued
29/06/2016
Revision
1

Assessment history

Enzepi : EPAR - Procedural steps taken and scientific information after authorisation

Enzepi : EPAR - Public assessment report

CHMP summary of opinion for Enzepi

Topics

This page was last updated on

How useful do you find this page?